ARTICLE
|
doi:10.20944/preprints201809.0591.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
adverse events; immune checkpoint inhibitor; myasthenia gravis; myopathy; neuropathy; nivolumab; pembrolizumab
Online: 29 September 2018 (11:28:00 CEST)
ARTICLE
|
doi:10.20944/preprints202011.0742.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Psilocybin; psychedelics; neuroplasticity; SV2A; 5-HT2A; depression; autoradiography; functional-selectivity
Online: 30 November 2020 (16:30:03 CET)